A Phase 1B, Multi-Center, Open-Label, Dose Finding Study of Cc-122 in Combination With Sorafenib in Subjects With . . . Grant uri icon

total award amount

  • 9600.00

direct costs

  • 7500.00

sponsor award ID

  • CC-122-HCC-001

local award ID

  • 00096751